<DOC>
	<DOC>NCT02259985</DOC>
	<brief_summary>food interaction, pharmacokinetics, safety and tolerability</brief_summary>
	<brief_title>Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>all participants in the study will range from 21 to 50 years of age and be within + 20% of their normal weight (Brocaindex) written informed consent in accordance with Good Clinical Practica and local legislation Subjects will be excluded from the study if the results of the medical examination or laboratory tests are judged by the investigator to differ significantly from normal clinical values Subjects with known gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorders Subjects with diseases of the central nervous system (such as epilepsy) or with psychiatric disorders Subjects with known history of orthostatic hypotension, fainting spells or blackouts Subjects with chronic or relevant acute infections Subjects with history of allergy/hypersensitivity (including drug allergy) which is deemed relevant to the trial as judged by the investigator Subjects who have taken a drug with a long halflife (&gt;= 24 hours) within one month before enrolment in the study Subjects who received any other drugs which might influence the results of the trial during the week previous the start of the study Subjects who have participated in another study with an investigational drug within the last 2 months preceding this study Subjects who are unable to refrain from smoking on study days Subjects who smoke more than 10 cigarettes (or 3 cigars or pipes) per day Subjects who drink more than 60 g of alcohol per day Subjects who are dependent on drugs Subjects who have donated blood (&gt;= 100 ml) within the last 4 weeks Subjects who participated in excessive physical activities (e.g. competitive sports) within the last week before the study</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>